CRISPR Co-Founder Jennifer Doudna on Future of Biotech

The video discusses the future impact of gene editing technology, particularly CRISPR, over the next decade. It highlights the convergence of biology and computer science, investment opportunities, and ethical considerations. The discussion also touches on the lessons learned from the COVID-19 pandemic and the role of mRNA technology in vaccine development.

How can the scientific community ensure appropriate transparency in gene editing advancements?

What role do you believe investment firms should play in the development of gene editing technologies?

What lessons do you think have been learned from the COVID-19 pandemic regarding preparedness for future pandemics?